Global Hemophilia Drugs Market Insights and Forecast to 2026

Global Hemophilia Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Hemophilia Drugs Product Introduction
1.2 Market Segments
1.3 Key Hemophilia Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hemophilia Drugs Market Size Growth Rate by Type
1.4.2 Hemophilia A
1.4.3 Inhibitors
1.4.4 Hemophilia B
1.4.5 Von Willebrand Disease
1.5 Market by Application
1.5.1 Global Hemophilia Drugs Market Size Growth Rate by Application
1.5.2 Recombinant Therapies
1.5.3 Plasma-Derived Therapies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hemophilia Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hemophilia Drugs Revenue 2015-2026
2.1.2 Global Hemophilia Drugs Sales 2015-2026
2.2 Global Hemophilia Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hemophilia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hemophilia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hemophilia Drugs Competitor Landscape by Players
3.1 Hemophilia Drugs Sales by Manufacturers
3.1.1 Hemophilia Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hemophilia Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hemophilia Drugs Revenue by Manufacturers
3.2.1 Hemophilia Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hemophilia Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hemophilia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hemophilia Drugs Revenue in 2019
3.2.5 Global Hemophilia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hemophilia Drugs Price by Manufacturers
3.4 Hemophilia Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hemophilia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemophilia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hemophilia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hemophilia Drugs Market Size by Type (2015-2020)
4.1.1 Global Hemophilia Drugs Sales by Type (2015-2020)
4.1.2 Global Hemophilia Drugs Revenue by Type (2015-2020)
4.1.3 Hemophilia Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hemophilia Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hemophilia Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hemophilia Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hemophilia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hemophilia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hemophilia Drugs Market Size by Application (2015-2020)
5.1.1 Global Hemophilia Drugs Sales by Application (2015-2020)
5.1.2 Global Hemophilia Drugs Revenue by Application (2015-2020)
5.1.3 Hemophilia Drugs Price by Application (2015-2020)
5.2 Hemophilia Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hemophilia Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hemophilia Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hemophilia Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hemophilia Drugs by Country
6.1.1 North America Hemophilia Drugs Sales by Country
6.1.2 North America Hemophilia Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hemophilia Drugs Market Facts & Figures by Type
6.3 North America Hemophilia Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hemophilia Drugs by Country
7.1.1 Europe Hemophilia Drugs Sales by Country
7.1.2 Europe Hemophilia Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hemophilia Drugs Market Facts & Figures by Type
7.3 Europe Hemophilia Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hemophilia Drugs by Region
8.1.1 Asia Pacific Hemophilia Drugs Sales by Region
8.1.2 Asia Pacific Hemophilia Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hemophilia Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hemophilia Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hemophilia Drugs by Country
9.1.1 Latin America Hemophilia Drugs Sales by Country
9.1.2 Latin America Hemophilia Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hemophilia Drugs Market Facts & Figures by Type
9.3 Central & South America Hemophilia Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hemophilia Drugs by Country
10.1.1 Middle East and Africa Hemophilia Drugs Sales by Country
10.1.2 Middle East and Africa Hemophilia Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hemophilia Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hemophilia Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Baxalta
11.1.1 Baxalta Corporation Information
11.1.2 Baxalta Description and Business Overview
11.1.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxalta Hemophilia Drugs Products Offered
11.1.5 Baxalta Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description and Business Overview
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Hemophilia Drugs Products Offered
11.2.5 Bayer Related Developments
11.3 CSL Behring
11.3.1 CSL Behring Corporation Information
11.3.2 CSL Behring Description and Business Overview
11.3.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Behring Hemophilia Drugs Products Offered
11.3.5 CSL Behring Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Hemophilia Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Corporation Information
11.5.2 Alnylam Pharmaceuticals Description and Business Overview
11.5.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Alnylam Pharmaceuticals Hemophilia Drugs Products Offered
11.5.5 Alnylam Pharmaceuticals Related Developments
11.6 BioMarin
11.6.1 BioMarin Corporation Information
11.6.2 BioMarin Description and Business Overview
11.6.3 BioMarin Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BioMarin Hemophilia Drugs Products Offered
11.6.5 BioMarin Related Developments
11.7 Catalyst Biosciences
11.7.1 Catalyst Biosciences Corporation Information
11.7.2 Catalyst Biosciences Description and Business Overview
11.7.3 Catalyst Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Catalyst Biosciences Hemophilia Drugs Products Offered
11.7.5 Catalyst Biosciences Related Developments
11.8 Dimension Therapeutics
11.8.1 Dimension Therapeutics Corporation Information
11.8.2 Dimension Therapeutics Description and Business Overview
11.8.3 Dimension Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dimension Therapeutics Hemophilia Drugs Products Offered
11.8.5 Dimension Therapeutics Related Developments
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Corporation Information
11.9.2 F. Hoffmann-La Roche Description and Business Overview
11.9.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 F. Hoffmann-La Roche Hemophilia Drugs Products Offered
11.9.5 F. Hoffmann-La Roche Related Developments
11.10 Grifols
11.10.1 Grifols Corporation Information
11.10.2 Grifols Description and Business Overview
11.10.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Grifols Hemophilia Drugs Products Offered
11.10.5 Grifols Related Developments
11.1 Baxalta
11.1.1 Baxalta Corporation Information
11.1.2 Baxalta Description and Business Overview
11.1.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxalta Hemophilia Drugs Products Offered
11.1.5 Baxalta Related Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Corporation Information
11.12.2 Sangamo Biosciences Description and Business Overview
11.12.3 Sangamo Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sangamo Biosciences Products Offered
11.12.5 Sangamo Biosciences Related Developments
11.13 Spark Therapeutics
11.13.1 Spark Therapeutics Corporation Information
11.13.2 Spark Therapeutics Description and Business Overview
11.13.3 Spark Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Spark Therapeutics Products Offered
11.13.5 Spark Therapeutics Related Developments
11.14 Swedish Orphan Biovitrum
11.14.1 Swedish Orphan Biovitrum Corporation Information
11.14.2 Swedish Orphan Biovitrum Description and Business Overview
11.14.3 Swedish Orphan Biovitrum Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Swedish Orphan Biovitrum Products Offered
11.14.5 Swedish Orphan Biovitrum Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hemophilia Drugs Market Estimates and Projections by Region
12.1.1 Global Hemophilia Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hemophilia Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hemophilia Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hemophilia Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hemophilia Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hemophilia Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hemophilia Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hemophilia Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hemophilia Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hemophilia Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hemophilia Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hemophilia Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hemophilia Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hemophilia Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hemophilia Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hemophilia Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hemophilia Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hemophilia Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hemophilia Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hemophilia Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hemophilia Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hemophilia Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hemophilia Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemophilia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Hemophilia Drugs Market Segments
Table 2. Ranking of Global Top Hemophilia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hemophilia Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Hemophilia A
Table 5. Major Manufacturers of Inhibitors
Table 6. Major Manufacturers of Hemophilia B
Table 7. Major Manufacturers of Von Willebrand Disease
Table 8. Global Hemophilia Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Hemophilia Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Hemophilia Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Hemophilia Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Hemophilia Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Hemophilia Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Hemophilia Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Hemophilia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Hemophilia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Drugs as of 2019)
Table 17. Hemophilia Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Hemophilia Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Hemophilia Drugs Price (2015-2020) (USD/MT)
Table 20. Hemophilia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Hemophilia Drugs Product Type
Table 22. Date of International Manufacturers Enter into Hemophilia Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 25. Global Hemophilia Drugs Sales Share by Type (2015-2020)
Table 26. Global Hemophilia Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Hemophilia Drugs Revenue Share by Type (2015-2020)
Table 28. Hemophilia Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 30. Global Hemophilia Drugs Sales Share by Application (2015-2020)
Table 31. North America Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 32. North America Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 36. North America Hemophilia Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 38. North America Hemophilia Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 40. Europe Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 44. Europe Hemophilia Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 46. Europe Hemophilia Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Hemophilia Drugs Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Hemophilia Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Hemophilia Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Hemophilia Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Hemophilia Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Hemophilia Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 56. Latin America Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 60. Latin America Hemophilia Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 62. Latin America Hemophilia Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Hemophilia Drugs Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Hemophilia Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hemophilia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Hemophilia Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Hemophilia Drugs Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Hemophilia Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Hemophilia Drugs Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Hemophilia Drugs Sales Market Share by Application (2015-2020)
Table 71. Baxalta Corporation Information
Table 72. Baxalta Description and Major Businesses
Table 73. Baxalta Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Baxalta Product
Table 75. Baxalta Recent Development
Table 76. Bayer Corporation Information
Table 77. Bayer Description and Major Businesses
Table 78. Bayer Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Bayer Product
Table 80. Bayer Recent Development
Table 81. CSL Behring Corporation Information
Table 82. CSL Behring Description and Major Businesses
Table 83. CSL Behring Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. CSL Behring Product
Table 85. CSL Behring Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. Alnylam Pharmaceuticals Corporation Information
Table 92. Alnylam Pharmaceuticals Description and Major Businesses
Table 93. Alnylam Pharmaceuticals Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Alnylam Pharmaceuticals Product
Table 95. Alnylam Pharmaceuticals Recent Development
Table 96. BioMarin Corporation Information
Table 97. BioMarin Description and Major Businesses
Table 98. BioMarin Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. BioMarin Product
Table 100. BioMarin Recent Development
Table 101. Catalyst Biosciences Corporation Information
Table 102. Catalyst Biosciences Description and Major Businesses
Table 103. Catalyst Biosciences Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Catalyst Biosciences Product
Table 105. Catalyst Biosciences Recent Development
Table 106. Dimension Therapeutics Corporation Information
Table 107. Dimension Therapeutics Description and Major Businesses
Table 108. Dimension Therapeutics Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Dimension Therapeutics Product
Table 110. Dimension Therapeutics Recent Development
Table 111. F. Hoffmann-La Roche Corporation Information
Table 112. F. Hoffmann-La Roche Description and Major Businesses
Table 113. F. Hoffmann-La Roche Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. F. Hoffmann-La Roche Product
Table 115. F. Hoffmann-La Roche Recent Development
Table 116. Grifols Corporation Information
Table 117. Grifols Description and Major Businesses
Table 118. Grifols Hemophilia Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Grifols Product
Table 120. Grifols Recent Development
Table 121. Octapharma Corporation Information
Table 122. Octapharma Description and Major Businesses
Table 123. Octapharma Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Octapharma Product
Table 125. Octapharma Recent Development
Table 126. Sangamo Biosciences Corporation Information
Table 127. Sangamo Biosciences Description and Major Businesses
Table 128. Sangamo Biosciences Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Sangamo Biosciences Product
Table 130. Sangamo Biosciences Recent Development
Table 131. Spark Therapeutics Corporation Information
Table 132. Spark Therapeutics Description and Major Businesses
Table 133. Spark Therapeutics Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Spark Therapeutics Product
Table 135. Spark Therapeutics Recent Development
Table 136. Swedish Orphan Biovitrum Corporation Information
Table 137. Swedish Orphan Biovitrum Description and Major Businesses
Table 138. Swedish Orphan Biovitrum Hemophilia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Swedish Orphan Biovitrum Product
Table 140. Swedish Orphan Biovitrum Recent Development
Table 141. Global Hemophilia Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 142. Global Hemophilia Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 143. Global Hemophilia Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 144. Global Hemophilia Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 145. North America: Hemophilia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 146. North America: Hemophilia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Europe: Hemophilia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 148. Europe: Hemophilia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Asia Pacific: Hemophilia Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 150. Asia Pacific: Hemophilia Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 151. Latin America: Hemophilia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 152. Latin America: Hemophilia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Middle East and Africa: Hemophilia Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 154. Middle East and Africa: Hemophilia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Hemophilia Drugs Players
Table 159. Hemophilia Drugs Customers List
Table 160. Hemophilia Drugs Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia Drugs Product Picture
Figure 2. Global Hemophilia Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Hemophilia A Product Picture
Figure 4. Inhibitors Product Picture
Figure 5. Hemophilia B Product Picture
Figure 6. Von Willebrand Disease Product Picture
Figure 7. Global Hemophilia Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Recombinant Therapies
Figure 9. Plasma-Derived Therapies
Figure 10. Hemophilia Drugs Report Years Considered
Figure 11. Global Hemophilia Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Hemophilia Drugs Sales 2015-2026 (K MT)
Figure 13. Global Hemophilia Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Hemophilia Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Hemophilia Drugs Sales Market Share by Region in 2019
Figure 16. Global Hemophilia Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Hemophilia Drugs Revenue Market Share by Region in 2019
Figure 18. Global Hemophilia Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Hemophilia Drugs Revenue in 2019
Figure 20. Hemophilia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Hemophilia Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Hemophilia Drugs Sales Market Share by Type in 2019
Figure 23. Global Hemophilia Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Hemophilia Drugs Revenue Market Share by Type in 2019
Figure 25. Global Hemophilia Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Hemophilia Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Hemophilia Drugs Sales Market Share by Application in 2019
Figure 28. Global Hemophilia Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Hemophilia Drugs Revenue Market Share by Application in 2019
Figure 30. North America Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Hemophilia Drugs Sales Market Share by Country in 2019
Figure 33. North America Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Hemophilia Drugs Market Share by Type in 2019
Figure 39. North America Hemophilia Drugs Market Share by Application in 2019
Figure 40. Europe Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Hemophilia Drugs Sales Market Share by Country in 2019
Figure 43. Europe Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Hemophilia Drugs Market Share by Type in 2019
Figure 55. Europe Hemophilia Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Hemophilia Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Hemophilia Drugs Revenue Market Share by Region in 2019
Figure 60. China Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Hemophilia Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Hemophilia Drugs Market Share by Application in 2019
Figure 84. Latin America Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Hemophilia Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Hemophilia Drugs Market Share by Type in 2019
Figure 95. Latin America Hemophilia Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Hemophilia Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Hemophilia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Hemophilia Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Hemophilia Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Hemophilia Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Hemophilia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Hemophilia Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Hemophilia Drugs Market Share by Application in 2019
Figure 108. North America Hemophilia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Hemophilia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Hemophilia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Hemophilia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Hemophilia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Hemophilia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Hemophilia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Hemophilia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Hemophilia Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Hemophilia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profil

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs